首页 正文

Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma

{{output}}
Glioblastoma, a grade IV astrocytoma, typically has a poor prognosis, with most patients succumbing within eighteen months of diagnosis and few experiencing long-term survival. Focused ultrasound, an emerging localized therapy, has shown promising results in e... ...